Long-term outcomes of late course accelerated hyper-fractionated radiotherapy for localized esophageal carcinoma in Mainland China: a meta-analysis
Authors:
- 10 February 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 24 (7) , 495-501
Abstract
Published data on the long-term survival results of patients with localized esophageal carcinoma receiving late course accelerated hyper-fractionated radiotherapy (LCAF RT) versus conventional fractionated radiotherapy (CF RT) are inconclusive. In order to derive a more precise estimation of the both treatment-regimes, a meta-analysis based on systematic review of published articles was performed. A meta-analysis was performed using trials identified through Pubmed and Chinese national knowledge infrastructure. Results in 5-year survival and 5-year local control were collected from randomized trials comparing LCAF RT with CF RT. Review Manager (The Cochrane Collaboration, Oxford, England) and Stata software (Stata Corporation, College Station, TX, USA) were used for data management. A total of 11 trials were involved in this analysis with 572 cases and 567 controls. Our results showed that LCAF RT, compared with CF RT, significantly improved the 5-year survival (odds ratio [OR]= 2.93, 95% confidence interval [CI]: 2.15-4.00, P < 0.00001) and 5-year local control (OR = 3.96, 95% CI: 2.91-5.38, P < 0.00001). LCAF RT was more therapeutically beneficial than CF RT in the localized esophageal carcinoma.Keywords
This publication has 12 references indexed in Scilit:
- Esophageal adenocarcinoma arising in Barrett esophagusCancer Letters, 2009
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Epidemiology of oesophagogastric cancerBest Practice & Research Clinical Gastroenterology, 2007
- Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF)Radiotherapy and Oncology, 2007
- Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalitiesThe Lancet Oncology, 2007
- Late-course accelerated hyperfractionated radiotherapy for localized esophageal carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Late course accelerated fractionation in radiotherapy of esophageal carcinomaRadiotherapy and Oncology, 1999
- The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997
- Carcinoma of the esophagus. Pretreatment assessment, correlation of radiation treatment parameters with survival, and identification and management of radiation treatment failureCancer, 1979